MyFinsight
Home
About
Contact
lxrx: the income statement
Download
Download image
Comprehensive loss
-$12,726K
(80.20%↑ Y/Y)
Unrealized gain (loss) on
investments
$43K
(-92.07%↓ Y/Y)
Net loss
-$12,769K
(80.30%↑ Y/Y)
Interest income and other
$1,573K
(-54.33%↓ Y/Y)
Royalties and other
revenue
$20K
(122.22%↑ Y/Y)
Net product and
licensing...
$13,154K
Net product and
licensing...
$1,008K
Interest and other
expense
$2,155K
(-52.76%↓ Y/Y)
Loss from operations
-$12,187K
(80.87%↑ Y/Y)
Total revenues
$14,182K
(710.40%↑ Y/Y)
Total operating
expenses
$26,369K
(-59.71%↓ Y/Y)
Selling, general and
administrative, including...
$7,602K
(-80.80%↓ Y/Y)
Research and development
$18,757K
(-27.24%↓ Y/Y)
Cost of sales
$10K
(-85.92%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
LEXICON PHARMACEUTICALS, INC. (LXRX)
LEXICON PHARMACEUTICALS, INC. (LXRX)